Regulation of Glucose Transporters - Implications for Insulin Resistance States

Altered glucose homeostasis in the different diabetic states often results from a combination of insulin deficiency (absolute or relative), and impaired hormone action. The latter involves alterations in the expression and/or function of glucose transporters in insulin responsive peripheral tissues - skeletal muscle and adipose tissue. Since whole body glucose utilization depends mainly on controlled changes in glucose transport in these tissues, this review focuses on the role of glucose transporters in the regulation of insulin-stimulated glucose transport activity. The molecular mechanisms by which several inducers of insulin resistance inhibit insulin action on glucose uptake are also discussed. Better understanding of the complex regulation of glucose transport and transporters will hopefully shed light on potential sites for new pharmaceutical interventions. Several excellent reviews have been published in the past 2 years detailing various aspects which are discussed only briefly in this review. They are mentioned in the text to allow further reading.

[1]  G. Striker.  Glucose toxicity. , 2001, Kidney international.

[2]  R. Somwar,et al.  An Inhibitor of p38 Mitogen-activated Protein Kinase Prevents Insulin-stimulated Glucose Transport but Not Glucose Transporter Translocation in 3T3-L1 Adipocytes and L6 Myotubes* , 1999, The Journal of Biological Chemistry.

[3]  C. Kahn,et al.  Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. , 1999, The Journal of clinical investigation.

[4]  R. Cooksey,et al.  Printed in U.S.A. Copyright © 1999 by The Endocrine Society Mechanism of Hexosamine-Induced Insulin Resistance in Transgenic Mice Overexpressing Glutamine:Fructose-6- Phosphate Amidotransferase: Decreased Glucose Transporter GLUT4 Translocation and Revers , 2022 .

[5]  D L Rothman,et al.  Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. , 1999, The Journal of clinical investigation.

[6]  S. J. Weiss.  Renewing the spirit. , 1999, The Journal of clinical investigation.

[7]  T. Yoshikawa,et al.  Insulin resistance in cancer patients is associated with enhanced tumor necrosis factor-alpha expression in skeletal muscle. , 1998, Biochemical and biophysical research communications.

[8]  K. Siddle,et al.  Phosphoinositide 3-kinase: the key switch in insulin signalling , 1998 .

[9]  A. Rudich,et al.  Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. , 1998, Diabetes.

[10]  H. Heimberg,et al.  Glucosamine-induced Insulin Resistance in 3T3-L1 Adipocytes Is Caused by Depletion of Intracellular ATP* , 1998, The Journal of Biological Chemistry.

[11]  Honglin Zhou,et al.  Inhibition of Akt Kinase by Cell-permeable Ceramide and Its Implications for Ceramide-induced Apoptosis* , 1998, The Journal of Biological Chemistry.

[12]  J. Lippincott-Schwartz,et al.  Retrograde Transport of Golgi-localized Proteins to the ER , 1998, The Journal of cell biology.

[13]  D. Brindley,et al.  Effects of Cell-Permeable Ceramides and Tumor Necrosis Factor-α on Insulin Signaling and Glucose Uptake in 3T3-L1 Adipocytes , 1998, Diabetes.

[14]  J. Zierath,et al.  Improved Glucose Tolerance Restores Insulin-Stimulated Akt Kinase Activity and Glucose Transport in Skeletal Muscle From Diabetic Goto-Kakizaki Rats , 1997, Diabetes.

[15]  Hui Chen,et al.  Effects of overexpression of glutamine:fructose-6-phosphate amidotransferase (GFAT) and glucosamine treatment on translocation of GLUT4 in rat adipose cells , 1997, Molecular and Cellular Endocrinology.

[16]  M. Quon,et al.  Insulin Receptor Substrate-2 (IRS-2) Can Mediate the Action of Insulin to Stimulate Translocation of GLUT4 to the Cell Surface in Rat Adipose Cells* , 1997, The Journal of Biological Chemistry.

[17]  G. Dohm,et al.  Mechanisms by which insulin and muscle contraction stimulate glucose transport. , 1997, Canadian journal of applied physiology = Revue canadienne de physiologie appliquee.

[18]  D. James,et al.  Moving GLUT4: The Biogenesis and Trafficking of GLUT4 Storage Vesicles , 1997, Diabetes.

[19]  R. Santer,et al.  Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome , 1997, Nature Genetics.

[20]  K. Uysal,et al.  Protection from obesity-induced insulin resistance in mice lacking TNF-α function , 1997, Nature.

[21]  A. Wells,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Fatty Acid-Induced Insulin Resistance in Adipocytes* , 2022 .

[22]  Mark A. Stephenson,et al.  Overexpression of glut1 and glut3 in stage I nonsmall cell lung carcinoma is Associated with poor survival , 1997, Cancer.

[23]  G. Lienhard,et al.  A Novel 160-kDa Phosphotyrosine Protein in Insulin-treated Embryonic Kidney Cells Is a New Member of the Insulin Receptor Substrate Family* , 1997, The Journal of Biological Chemistry.

[24]  M. Kasuga,et al.  From receptor to transporter: insulin signalling to glucose transport , 1997, Diabetologia.

[25]  D. McClain,et al.  Activation of the Hexosamine Pathway by Glucosamine in Vivo Induces Insulin Resistance in Multiple Insulin Sensitive Tissues. , 1997, Endocrinology.

[26]  M. Williams,et al.  Development of Insulin Resistance in 3T3-L1 Adipocytes* , 1997, The Journal of Biological Chemistry.

[27]  T. Hansen,et al.  Identification of a Common Amino Acid Polymorphism in the p85α Regulatory Subunit of Phosphatidylinositol 3-Kinase: Effects on Glucose Disappearance Constant, Glucose Effectiveness, and the Insulin Sensitivity Index , 1997, Diabetes.

[28]  J. Zierath,et al.  Insulin Receptor Substrate-1 Phosphorylation and Phosphatidylinositol 3-Kinase Activity in Skeletal Muscle From NIDDM Subjects After In Vivo Insulin Stimulation , 1997, Diabetes.

[29]  G. Boden.  Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM , 1997, Diabetes.

[30]  K. Uysal,et al.  Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. , 1997, Nature.

[31]  U. Eriksson,et al.  Teratogenic effect of diabetic serum is prevented by supplementation of superoxide dismutase and N-acetylcysteine in rat embryo culture , 1997, Diabetologia.

[32]  D. McClain,et al.  Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. , 1996, The Journal of clinical investigation.

[33]  D. McClain,et al.  Hexosamines and Insulin Resistance , 1996, Diabetes.

[34]  Roy Taylor,et al.  Effects of an Engineered Human Anti–TNF-α Antibody (CDP571) on Insulin Sensitivity and Glycemic Control in Patients With NIDDM , 1996, Diabetes.

[35]  K. Petersen,et al.  Mechanism of free fatty acid-induced insulin resistance in humans. , 1996, The Journal of clinical investigation.

[36]  B. Spiegelman,et al.  Tumor Necrosis Factor (TNF)-α Inhibits Insulin Signaling through Stimulation of the p55 TNF Receptor and Activation of Sphingomyelinase* , 1996, The Journal of Biological Chemistry.

[37]  M. Papa,et al.  Sphingomyelinase and Ceramide Suppress Insulin-induced Tyrosine Phosphorylation of the Insulin Receptor Substrate-1 (*) , 1996, The Journal of Biological Chemistry.

[38]  A. Ullrich,et al.  Tumor necrosis factor-alpha- and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signaling. , 1996, The Journal of clinical investigation.

[39]  A. Saltiel.  Diverse signaling pathways in the cellular actions of insulin. , 1996, The American journal of physiology.

[40]  R. DeFronzo,et al.  Increased Glutamine:Fructose-6-Phosphate Amidotransferase Activity in Skeletal Muscle of Patients With NIDDM , 1996, Diabetes.

[41]  G. Paolisso,et al.  Oxidative Stress and Diabetic Vascular Complications , 1996, Diabetes Care.

[42]  R. Henry,et al.  The expression of TNF alpha by human muscle. Relationship to insulin resistance. , 1996, The Journal of clinical investigation.

[43]  A. Stenbit,et al.  Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4 , 1995, Nature.

[44]  D. Betteridge,et al.  Elevated Levels of Authentic Plasma Hydroperoxides in NIDDM , 1995, Diabetes.

[45]  E. Van Obberghen,et al.  Wortmannin inhibits the action of insulin but not that of okadaic acid in skeletal muscle: comparison with fat cells. , 1995, Endocrinology.

[46]  S. Jacob,et al.  Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid. , 1995, Arzneimittel-Forschung.

[47]  L. Rossetti.  Glucose toxicity: the implications of hyperglycemia in the pathophysiology of diabetes mellitus. , 1995, Clinical and investigative medicine. Medecine clinique et experimentale.

[48]  G. Reaven,et al.  Pathophysiology of insulin resistance in human disease. , 1995, Physiological reviews.

[49]  Wei Chen,et al.  In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats. , 1995, The Journal of clinical investigation.

[50]  D. Zheng,et al.  Skeletal Muscle GLUT4 Protein Concentration and Aging in Humans , 1995, Diabetes.

[51]  B. Spiegelman,et al.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.

[52]  J. Pessin,et al.  Skeletal muscle glucose transport and metabolism are enhanced in transgenic mice overexpressing the Glut4 glucose transporter. , 1995, The Journal of biological chemistry.

[53]  A. Schmidt,et al.  Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[54]  B. Spiegelman,et al.  Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. , 1994, The Journal of clinical investigation.

[55]  M. Mueckler,et al.  Glucose transport activity in skeletal muscles from transgenic mice overexpressing GLUT1. Increased basal transport is associated with a defective response to diverse stimuli that activate GLUT4. , 1994, The Journal of biological chemistry.

[56]  K. Asayama,et al.  Serum Antioxidant Status in Streptozotocin-Induced Diabetic Rat , 1994, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[57]  F. Dela,et al.  Physical Training Increases Muscle GLUT4 Protein and mRNA in Patients With NIDDM , 1994, Diabetes.

[58]  Y. Zou,et al.  Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. , 1994, The Journal of biological chemistry.

[59]  T. Okada,et al.  Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. , 1994, The Journal of biological chemistry.

[60]  M. Mueckler.  Facilitative glucose transporters. , 1994, European journal of biochemistry.

[61]  C. Kahn,et al.  The insulin signaling system. , 1994, The Journal of biological chemistry.

[62]  F. DeRubertis,et al.  Activation of Protein Kinase C in Glomerular Cells in Diabetes: Mechanisms and Potential Links to the Pathogenesis of Diabetic Glomerulopathy , 1994, Diabetes.

[63]  B. Caballero,et al.  Vitamin E improves the action of insulin. , 2009, Nutrition reviews.

[64]  M. Papa,et al.  Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. , 1993, The Journal of biological chemistry.

[65]  J. Olefsky,et al.  Potential role for insulin and cycloheximide in regulating the intrinsic activity of glucose transporters in isolated rat adipocytes. , 1993, Endocrinology.

[66]  P. Neufer,et al.  Exercise induces a transient increase in transcription of the GLUT-4 gene in skeletal muscle. , 1993, The American journal of physiology.

[67]  S. Baldwin,et al.  Mammalian passive glucose transporters: members of an ubiquitous family of active and passive transport proteins. , 1993, Biochimica et biophysica acta.

[68]  G. Dohm,et al.  Exercise training increases GLUT-4 protein concentration in previously sedentary middle-aged men. , 1993, The American journal of physiology.

[69]  D. Chisholm,et al.  The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. , 1993, The New England journal of medicine.

[70]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[71]  B. Thorens,et al.  Facilitated glucose transporters in epithelial cells. , 1993, Annual review of physiology.

[72]  É. Brot-Laroche,et al.  Expression and localization of GLUT-5 in Caco-2 cells, human small intestine, and colon. , 1992, The American journal of physiology.

[73]  J. Olefsky,et al.  Evidence that glucose transport is rate-limiting for in vivo glucose uptake. , 1992, Metabolism: clinical and experimental.

[74]  A. Marette,et al.  Abundance, localization, and insulin-induced translocation of glucose transporters in red and white muscle. , 1992, The American journal of physiology.

[75]  B. Kahn.  Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes. , 1992, The Journal of clinical investigation.

[76]  C. Burant,et al.  Human intestinal glucose transporter expression and localization of GLUT5. , 1992, The American journal of physiology.

[77]  J. Kornhauser,et al.  Glucose transporter expression in brain. cDNA sequence of mouse GLUT3, the brain facilitative glucose transporter isoform, and identification of sites of expression by in situ hybridization. , 1992, The Journal of biological chemistry.

[78]  J. Olefsky,et al.  Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLUT-4) in patients with common-type non-insulin-dependent diabetes mellitus. , 1991, The Journal of clinical investigation.

[79]  S. Harik,et al.  Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. , 1991, The New England journal of medicine.

[80]  S. Marshall,et al.  Complete inhibition of glucose-induced desensitization of the glucose transport system by inhibitors of mRNA synthesis. Evidence for rapid turnover of glutamine:fructose-6-phosphate amidotransferase. , 1991, The Journal of biological chemistry.

[81]  S. Marshall,et al.  Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. , 1991, The Journal of biological chemistry.

[82]  M. Birnbaum,et al.  Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity. , 1991, The Journal of clinical investigation.

[83]  D. James,et al.  Differential sorting of two glucose transporters expressed in insulin-sensitive cells. , 1991, The American journal of physiology.

[84]  J. Friedman,et al.  Decreased expression of glucose transporter in muscle from insulin-resistant patients. , 1991, The American journal of physiology.

[85]  S. Wolff,et al.  Protein glycation and oxidative stress in diabetes mellitus and ageing. , 1991, Free radical biology & medicine.

[86]  J. Flier,et al.  Evidence Against Altered Expression of GLUT1 or GLUT4 in Skeletal Muscle of Patients With Obesity or NIDDM , 1990, Diabetes.

[87]  A. Klip,et al.  Glycation of the human erythrocyte glucose transporter in vitro and its functional consequences. , 1990, The Biochemical journal.

[88]  V. Mohsenin,et al.  Respiratory burst in alveolar macrophages of diabetic rats. , 1990, Journal of applied physiology.

[89]  G I Bell,et al.  Molecular Biology of Mammalian Glucose Transporters , 1990, Diabetes Care.

[90]  H. Lodish,et al.  Molecular Physiology of Glucose Transporters , 1990, Diabetes Care.

[91]  A. Zorzano,et al.  Insulin-regulated glucose uptake in rat adipocytes is mediated by two transporter isoforms present in at least two vesicle populations. , 1989, The Journal of biological chemistry.

[92]  M. Birnbaum.  Identification of a novel gene encoding an insulin-responsive glucose transporter protein , 1989, Cell.

[93]  B. Sugden.  An intricate route to immortality , 1989, Cell.

[94]  H. Lodish,et al.  A glucose transport protein expressed predominately in insulin-responsive tissues. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[95]  C Bogardus,et al.  No accumulation of glucose in human skeletal muscle during euglycemic hyperinsulinemia. , 1988, The American journal of physiology.

[96]  H. Lodish,et al.  Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and β-pancreatic islet cells , 1988, Cell.

[97]  M. Crumpton,et al.  Diversity in the lipocortin/calpactin family , 1988, Cell.

[98]  J. Lunec,et al.  Serum antioxidant activity in diabetes mellitus. , 1988, Diabetes research.

[99]  G. Reaven,et al.  Additive Hypoglycemic Effects of Drugs That Modify Free-Fatty Acid Metabolism by Different Mechanisms in Rats With Streptozocin-Induced Diabetes , 1988, Diabetes.

[100]  H. Lodish,et al.  Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells. , 1988, Cell.

[101]  J. Lunec,et al.  Vitamin C metabolites and microangiopathy in diabetes mellitus. , 1987, Diabetes research.

[102]  H. Yki-Järvinen,et al.  Kinetics of glucose disposal in whole body and across the forearm in man. , 1987, The Journal of clinical investigation.

[103]  R. Rizza,et al.  Effects of tolazamide and exogenous insulin on insulin action in patients with non-insulin-dependent diabetes mellitus. , 1986, The New England journal of medicine.

[104]  G. Reaven,et al.  Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. , 1985, The Journal of clinical endocrinology and metabolism.

[105]  T. O'dorisio,et al.  Production of 12-Hydroxyeicosatetraenoic Acid and Vitamin E Status in Platelets from Type I Human Diabetic Subjects , 1985, Diabetes.

[106]  R. Hamman,et al.  The Effect of Insulin Treatment on Insulin Secretion and Insulin Action in Type II Diabetes Mellitus , 1985, Diabetes.

[107]  H. Yki-Järvinen,et al.  Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy. , 1984, The Journal of clinical endocrinology and metabolism.

[108]  H. Beck-Nielsen,et al.  Improved In Vivo Insulin Effect During Continuous Subcutaneous Insulin Infusion in Patients with IDDM , 1984, Diabetes.

[109]  W. J. Andrews,et al.  Insulin Therapy in Obese, Non-insulin-dependent Diabetes Induces Improvements in Insulin Action and Secretion that Are Maintained for Two Weeks After Insulin Withdrawal , 1984, Diabetes.

[110]  S. Chari,et al.  Glutathione and Its Redox System in Diabetic Polymorphonuclear Leukocytes , 1984, The American journal of the medical sciences.

[111]  S. Cushman,et al.  Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane. , 1980, The Journal of biological chemistry.

[112]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.